Clik here to view.
Sterigenics International LLC Changes Name to Sotera Health LLC
CLEVELAND Sterigenics International LLC (the “Company”) announced today that it has changed its parent company name to Sotera Health LLC. Its three operating companies – Nelson Labs™, Nordion® and...
View ArticleClik here to view.
Chugai’s ALK Inhibitor “Alecensa®” Approved for the Treatment of First Line...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Genentech Inc., a member of the Roche Group, obtained approval from the U.S. Food and Drug Administration (FDA), for...
View ArticleClik here to view.
Strategic Minority Investment Company MiNA Therapeutics Enters Into...
TOKYO Sosei Group Corporation (‘Sosei’; TSE Mothers Index 4565), is pleased to note that our strategic minority investment company MiNA Therapeutics (‘MiNA’) has announced a collaboration and...
View ArticleClik here to view.
Seattle Genetics and Astellas Initiate Phase 1b Trial of Enfortumab Vedotin...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”), today announced dosing of the first patient...
View ArticleClik here to view.
Cerveau Technologies, Inc. Signs Research Agreement with Houston Methodist
BOSTON Cerveau Technologies Inc. today announced an agreement with Houston Methodist Hospital to support multiple projects over the next several years. These research projects are for studies of an...
View ArticleClik here to view.
Progenity宣布完成1.25亿美元融资，用于产前-女性健康遗传学和胃肠病/炎性肠病精准医学
圣迭戈 (美国商业资讯) — 私营生物技术公司Progenity Inc.今天宣布完成一笔包含资产和债务的价值1.25亿美元的私募B轮融资。该融资由其现有的投资者之一Athyrium Capital Management掌管的一家基金领投。 Progenity Inc.执行董事长、创始人Harry...
View ArticleClik here to view.
Orthocell Receives CE Mark for CelGro®
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce receipt of European regulatory approval (CE Mark) for its CelGro®...
View ArticleClik here to view.
Sosei to Advance Clinical Development in Japan of HTL0018318 in Patients with...
TOKYO & LONDON Sosei Group Corporation (“Sosei”); TSE Mothers Index:4565) announces that it has agreed with Allergan to an amendment to the 2016 global R&D and commercialisation partnership...
View ArticleClik here to view.
FDA Accepts Otsuka’s Resubmission to Support a Regulatory Review of Tolvaptan...
TOKYO Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that the U.S. Food and Drug Administration (FDA) has accepted Otsuka’s resubmission to support a regulatory review of Otsuka’s New Drug...
View ArticleClik here to view.
プロジェニティ、妊婦医療の遺伝および消化管/炎症性腸疾患精密医学に向けた1億2500万ドルの資金調達の完了を発表
サンディエゴ （ビジネスワイヤ） — 非公開のバイオ技術企業のプロジェニティは本日、株式と負債で構成される私募による1億2500万ドルのシリーズB資金調達を完了したと発表しました。この資金調達は、既存の投資家のアシリアム・キャピタル・マネジメントが管理するファンドが主幹事を務めました。...
View ArticleClik here to view.
武田薬品が第59回米国血液学会年次総会で血液がん治療の未来を再形成し得るデータを発表へ
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
Global Good and Motic Introduce Breakthrough AI-Powered Microscope to Fight...
XIAMEN, China & BELLEVUE, Wash. Advanced microscope designer and manufacturer Motic China Group Co., Ltd, a subsidiary of Motic (Xiamen) Electric Group Co Ltd (SHE: 300341), announced today at...
View ArticleClik here to view.
SCIEX Announces Joint Venture With Zhenjang Dian Diagnostics in China
FRAMINGHAM, Mass. & SHANGHAI SCIEX Diagnostics, the in vitro diagnostics (IVD) division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that it has...
View ArticleClik here to view.
アレクシオン、従業員が地域社会の向上を図るボランティア活動を実施する第2回年次グローバル・デー・オブ・サービスを実施
米コネティカット州ニューヘイブン （ビジネスワイヤ） —...
View ArticleClik here to view.
Novel Antibodies against a Ground-Breaking New Target for the Treatment of...
CAMBRIDGE, England & SINGAPORE Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
Eternity Healthcare Inc. Announces Plans to Build a 50,000 Square Foot Stem...
NEW YORK Eternity Healthcare (“Eternity” or the “Company”) (OTC: ETAH) has announced its intention to build a cell storage, transformation and application facility in Tongren, Guizhou Province,...
View ArticleClik here to view.
武田的ADCETRIS® (brentuximab vedotin)获得CHMP肯定意见，用于治疗CD30阳性皮肤T细胞淋巴瘤
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，欧洲药品管理局(EMA)人用药品委员会(CHMP)已采纳一项肯定意见，延长ADCETRIS® (brentuximab...
View ArticleClik here to view.
Conavi Medical and China Grand Pharmaceutical and Healthcare Enter into...
TORONTO ConaviTM Medical Inc., a privately-held company developing image guidance technologies for minimally invasive procedures, is pleased to announce that it has entered into an agreement with an...
View ArticleClik here to view.
AstraZeneca to Present Transformative Data at ESMO Asia 2017 Congress from...
SINGAPORE At the ESMO Asia 2017 Congress in Singapore, 17-19 November 2017, AstraZeneca and MedImmune, its global biologics research and development arm, will share ground-breaking results from two...
View Article